Seravac Limited is a vaccine manufacturing company in Ghana focused on strengthening local and regional health security through pharmaceutical production. It is part of Ghana’s broader effort to build a sustainable vaccine industry that reduces dependence on imports and supports timely access to essential vaccines for public health needs.

The company operates a state‑of‑the‑art vaccine manufacturing facility located in Accra, Ghana, where it carries out fill‑and‑finish vaccine production—the final stages of preparing vaccines for distribution, including filling vials, sealing, and labelling. Seravac’s facility is designed to meet international quality standards, such as the World Health Organization’s Good Manufacturing Practices (GMP), ensuring that its products are safe, effective, and suitable for both local and regional use.

Beyond its current manufacturing activities, Seravac Limited is positioned to expand into fuller vaccine production—including active ingredient manufacturing and broader vaccine portfolios—to support Ghana’s long‑term goals of becoming a pharmaceutical hub in Africa. Its work contributes to building local expertise in vaccine research and production, strengthening healthcare infrastructure, and enhancing the continent’s ability to respond to disease outbreaks and public health challenges.